e-learning
resources
Munich 2006
Sunday 03.09.2006
Cystic fibrosis: aerosol treatment and non–pulmonary complications
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Microcirculation alterations in adult patients with cystic fibrosis
V. Nanou, A. Papamichalopoulos, E. Armeniakou, M. Avdikou, C. Pappas, E. Manos, V. Gerovasili, V. Georgiopoulou, G. Perpati, E. Pouliou, C. Roussos, S. Nanas (Athens, Greece)
Source:
Annual Congress 2006 - Cystic fibrosis: aerosol treatment and non–pulmonary complications
Session:
Cystic fibrosis: aerosol treatment and non–pulmonary complications
Session type:
Thematic Poster Session
Number:
1522
Disease area:
Airway diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Nanou, A. Papamichalopoulos, E. Armeniakou, M. Avdikou, C. Pappas, E. Manos, V. Gerovasili, V. Georgiopoulou, G. Perpati, E. Pouliou, C. Roussos, S. Nanas (Athens, Greece). Microcirculation alterations in adult patients with cystic fibrosis. Eur Respir J 2006; 28: Suppl. 50, 1522
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Genotype and progressive lung damage in adult cystic fibrosis patients
Source: Eur Respir J 2003; 22: Suppl. 45, 502s
Year: 2003
The ageing cystic fibrosis patient
Source: International Congress 2018 – PG18 Cystic fibrosis: management in adult patients
Year: 2018
Ergospirometry in children with cystic fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 229s
Year: 2003
Increased arterial stiffness in adult patients with cystic fibrosis
Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools
Year: 2008
Lung function in children with cystic fibrosis liver disease
Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects
Year: 2021
Relations between the sinonasal development and the lung disease in cystic fibrosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 103s
Year: 2005
The lung clearance index correlates with markers of pulmonary deterioration in patients with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
The peculiarities of basic metabolism in cystic fibrosis patients
Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies
Year: 2011
Fertility in adult cystic fibrosis
Source: International Congress 2018 – PG18 Cystic fibrosis: management in adult patients
Year: 2018
MRI detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014
Early renal involvement in children with cystic fibrosis.
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018
Pathophysiology of cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 1-13
Year: 2014
Hyperinflation in adult cystic fibrosis (CF) patients: Clinical and functional correlates
Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies
Year: 2010
Regular exercise improves airway inflammation in cystic fibrosis patients
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
Biomarkers of early relapse of pulmonary exacerbation in cystic fibrosis adult patients
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
Factors affecting lung function in adult cystic fibrosis patients after lung transplantation.
Source: International Congress 2018 – Evolving approaches to differential diagnosis
Year: 2018
Prevalence of renal impairment in an adult cystic fibrosis (CF) centre
Source: Eur Respir J 2005; 26: Suppl. 49, 622s
Year: 2005
Neomacrolides in cystic fibrosis
Source: Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease
Year: 2012
Temporal progression of fungal microbiota in patients with cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: assessment and treatment
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept